{
    "clinical_study": {
        "@rank": "111086", 
        "arm_group": [
            {
                "arm_group_label": "Injection, medications and application", 
                "arm_group_type": "Experimental", 
                "description": "Intravenous injection: Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co., Ltd;\nMedications: according to TCM syndrome differentiations;\nWind-heat blocking lungs pattern (feng re bi fei zheng): Xiaoer Qingfei Heji (mixture), and Zhi Ke San (herbal powder to relieve cough)\nPhlegm-heat blocking lungs pattern (tan re bi fei zheng): Xiaoer Qingfei Heji (mixture), and Hua Tan San (herbal powder to remove phlegm)\nExternal application: Fuxiong San"
            }, 
            {
                "arm_group_label": "Injection and medications", 
                "arm_group_type": "Active Comparator", 
                "description": "Intravenous injection: Ribavirin Injection;\nMedications: symptomatic therapies\nGuaifenesin Syrup, for removing phlegm, relieving gasp-cough;\nIbuprofen Suspension, and salbutamol in case of different symptoms"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the effectiveness of traditional Chinese medicine\n      for treatment of pediatric pneumonia. It is a multicenter randomized controlled trial."
        }, 
        "brief_title": "Effectiveness Study of Integrative Treatment for Pediatric Pneumonia", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "condition": "Pneumonia", 
        "condition_browse": {
            "mesh_term": "Pneumonia"
        }, 
        "detailed_description": {
            "textblock": "The retrospective case study has been finished at the National clinical research base of\n      traditional Chinese medicine for major disease pediatric pneumonia, and the research center\n      organized the field training of prospective-study to coordinated units. Based on the primary\n      statistical outcomes of retrospective case study and the discussion around prospective-study\n      during the training, investigators found it difficult to include simplex viral infection,\n      therefore, investigators revised the inclusion criteria and treatment protocol of the\n      pragmatic randomized controlled trial.\n\n      The block randomization is used in this trial. Random numbers are generated by SPSS\n      software. Statistical analysis staff and those who perform the follow-up are blinded. Sample\n      size calculation was performed, which was 369, and considering drop-out or withdrawal,\n      investigators plan to enroll 450 patients (300 in experimental group, 150 in control)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  children, aged 6 months to 59 months old, diagnosed as pneumonia according to western\n             medicine diagnostic criteria;\n\n          -  diagnosed as TCM pneumonia with gasp-cough, meeting wind-heat blocking lungs pattern\n             (feng re bi fei zheng), and phlegm-heat blocking lungs pattern (tan re bi fei zheng);\n\n          -  disease progression within 72 hours;\n\n          -  those whose guardians understood and assigned the informed consent;\n\n        Exclusion Criteria:\n\n          -  emergency pneumonia;\n\n          -  complicated with other Pulmonary Disorders attack other than pneumonia;\n\n          -  complicated with primary disease of heart (congenital heart disease, myocarditis, et\n             al), liver (ALT, and AST \u2265 1.5 times of normal value ceiling), kidney (BUN >\n             8.2mmol/L, or serum CR > 104 \u00b5mol/L, et al) and blood system (anemia), and those with\n             psychopathy;\n\n          -  allergic to interventional medications;\n\n          -  those who are participating or have participated in other clinical trials in 3\n             months."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "59 Months", 
            "minimum_age": "6 Months"
        }, 
        "enrollment": {
            "#text": "451", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02069665", 
            "org_study_id": "AHLN-TCM-01"
        }, 
        "intervention": [
            {
                "arm_group_label": "Injection, medications and application", 
                "description": "external application; 8-10cm wide, 0.3-0.5cm thick; 10mins for patient aged 1 to 3-year old; 15mins for those aged 3 to 5-year old; once daily", 
                "intervention_name": "Fuxiong San", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Injection, medications and application", 
                "description": "ivd. 5 to 10 mg/(kg\u2022d), plus 5% Glucose Injection, 80 to 100 ml, ivd. Once a day injection.", 
                "intervention_name": "Xiyanping injection", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Injection and medications", 
                "description": "ivd. 10 to 20 mg/(kg\u2022d), plus 5% Glucose Injection, 80 to 100 ml, ivd. Once a day injection.", 
                "intervention_name": "Ribavirin Injection", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Injection, medications and application", 
                "description": "children aged 6 months to 1 year old: 10 ml, orally taken three times daily; children aged 1 to 3 year old: 15 ml, orally taken three times daily; children aged 3 to 5 year old: 20 ml, orally taken three times daily;", 
                "intervention_name": "Xiaoer Qingfei Heji (mixture)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Injection, medications and application", 
                "description": "children aged 6 months to 1 year old: 0.5g, orally taken three times daily; children aged 1 to 3 year old: 1.5g, orally taken three times daily; children aged 3 to 5 year old: 2.0g, orally taken three times daily;", 
                "intervention_name": "Zhi Ke San", 
                "intervention_type": "Drug", 
                "other_name": "herbal powder to relieve cough"
            }, 
            {
                "arm_group_label": "Injection, medications and application", 
                "description": "children aged 6 months to 1 year old: 0.5g, orally taken three times daily; children aged 1 to 3 year old: 1.5g, orally taken three times daily; children aged 3 to 5 year old: 2.0g, orally taken three times daily;", 
                "intervention_name": "Hua Tan San", 
                "intervention_type": "Drug", 
                "other_name": "herbal powder to remove phlegm"
            }, 
            {
                "arm_group_label": "Injection and medications", 
                "description": "children aged 6 months to 1 year old: 3ml, orally taken three times daily; children aged 1 to 3 year old: 5ml, orally taken three times daily; children aged 3 to 5 year old: 8ml, orally taken three times daily;", 
                "intervention_name": "Guaifenesin Syrup", 
                "intervention_type": "Drug", 
                "other_name": "Guaifenesin, Methylephedrine and Chlorphenamine Syrup"
            }, 
            {
                "arm_group_label": "Injection and medications", 
                "description": "taken under prescription", 
                "intervention_name": "Ibuprofen Suspension", 
                "intervention_type": "Drug", 
                "other_name": "Motrin"
            }, 
            {
                "arm_group_label": "Injection and medications", 
                "description": "taken under prescription", 
                "intervention_name": "salbutamol", 
                "intervention_type": "Drug", 
                "other_name": "\u03b22\uff0dagonists"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Albuterol", 
                "Phenylpropanolamine", 
                "Chlorpheniramine, phenylpropanolamine drug combination", 
                "Chlorpheniramine", 
                "Ibuprofen", 
                "Guaifenesin", 
                "Ribavirin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "pneumonia", 
            "pediatrics", 
            "viral"
        ], 
        "lastchanged_date": "February 20, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "state": "Beijing", 
                        "zip": "100045"
                    }, 
                    "name": "Affiliated Children's Hospital of Capital University of Medical Sciences"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Guangzhou", 
                        "country": "China", 
                        "state": "Guangdong", 
                        "zip": "510120"
                    }, 
                    "name": "Guangzhou Children's Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dalian", 
                        "country": "China", 
                        "state": "Liaoning", 
                        "zip": "116044"
                    }, 
                    "name": "Affiliated Children's Hospital of Dalian Medical University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shenyang", 
                        "country": "China", 
                        "state": "Liaoning", 
                        "zip": "110032"
                    }, 
                    "name": "Affiliated Hospital of Liaoning University of TCM"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ji'nan", 
                        "country": "China", 
                        "state": "Shandong", 
                        "zip": "250011"
                    }, 
                    "name": "Affiliated Hospital of Shandong University of TCM"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China", 
                        "state": "Shanghai", 
                        "zip": "200032"
                    }, 
                    "name": "Affiliated Longhua Hospital of Shanghai University of TCM"
                }
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Assessing the Effectiveness of Integrative Treatment That Combines Interior and Exterior Treatment Plans in Pediatric Pneumonia: a Program by PRC National Clinical Research Base of Traditional Chinese Medicine for Major Diseases", 
        "other_outcome": {
            "description": "Medical cost including hospital expenses, examine fee, medication fee, et al, related to treatment in hospital", 
            "measure": "Direct medical cost", 
            "safety_issue": "No", 
            "time_frame": "observed during treatment in 10 days"
        }, 
        "overall_official": [
            {
                "affiliation": "Affiliated Hospital of Liaoning University of TCM", 
                "last_name": "Xuefeng Wang, Ph.D.", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Affiliated Hospital of Liaoning University of TCM", 
                "last_name": "Zhenqi Wu", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "China: State Administration of Traditional Chinese Medicine of the People's Republic of China", 
                "China: Ethics Committee"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Clinical symptoms and signs totally disappear, the period of lab tests return to normal is recorded.", 
                "measure": "Cured rate", 
                "safety_issue": "No", 
                "time_frame": "Every day since receiving treatment, all together 10 days (times)"
            }, 
            {
                "description": "days range from treatment is received to the effectiveness is observed, and symptoms disappear", 
                "measure": "Effectiveness time window", 
                "safety_issue": "No", 
                "time_frame": "Every day since receiving treatment, all together 10 days (times)"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02069665"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Liaoning University of Traditional Chinese Medicine", 
            "investigator_full_name": "Xuefeng Wang", 
            "investigator_title": "Chief physician", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Total effective rate according to TCM syndrome differentiation and treatment, and single syndrome effective rate", 
                "measure": "TCM syndrome scores and effective rate", 
                "safety_issue": "No", 
                "time_frame": "10 days"
            }, 
            {
                "description": "temperature, fever frequency, fever lasting time, Ibuprofen Suspension dosing; cough severity; phlegm amount, color and nature; gasp frequency, severity, all to be measured", 
                "measure": "Effect in fever, cough, phlegm and gasp", 
                "safety_issue": "No", 
                "time_frame": "10 days"
            }, 
            {
                "description": "days are counted since receiving treatment, when the chest radiograph returns to normal", 
                "measure": "Time of lung rales disappear completely", 
                "safety_issue": "No", 
                "time_frame": "10 days"
            }, 
            {
                "description": "days counted when the patient checks out", 
                "measure": "Check-out time", 
                "safety_issue": "No", 
                "time_frame": "10 days"
            }, 
            {
                "description": "unresolved pneumonia, chronic cough, cough variant asthma incidence in the follow-up", 
                "measure": "Pulmonary disease incidence", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }
        ], 
        "source": "Liaoning University of Traditional Chinese Medicine", 
        "sponsors": {
            "collaborator": {
                "agency": "Beijing University of Chinese Medicine", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Liaoning University of Traditional Chinese Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}